Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase.
about
The latent transforming growth factor beta binding protein (LTBP) familyPlatelet-derived growth factor modulates rat vascular smooth muscle cell responses on laminin-5 via mitogen-activated protein kinase-sensitive pathwaysSynergistic increase in nerve growth factor secretion by cultured vascular smooth muscle cells treated with injury-related growth factors.Blockade of TGF-β by catheter-based local intravascular gene delivery does not alter the in-stent neointimal response, but enhances inflammation in pig coronary arteries.TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscleMyogenic growth factors can decrease extraocular muscle force generation: a potential biological approach to the treatment of strabismus.Accelerated reendothelialization, increased neovascularization and erythrocyte extravasation after arterial injury in BAMBI-/- mice.Cold ischemia induces isograft arteriopathy, but does not augment allograft arteriopathy in non-immunosuppressed hostsLipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis.The association of functional polymorphisms in genes encoding growth factors for endothelial cells and smooth muscle cells with the severity of coronary artery disease.Young microglia restore amyloid plaque clearance of aged microglia.Conditional expression of TGF-β1 in skeletal muscles causes endomysial fibrosis and myofibers atrophyInflammatory markers in coronary artery disease.Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells.Mouse embryo-derived NIH3T3 fibroblasts adopt an osteoblast-like phenotype when treated with 1alpha,25-dihydroxyvitamin D(3) and dexamethasone in vitro.Induced elastic matrix deposition within three-dimensional collagen scaffolds.Ascending Aortic Proaneurysmal Genetic Mutations with Antiatherogenic EffectsRapid up-regulation of alpha4 integrin-mediated leukocyte adhesion by transforming growth factor-beta1.Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2.A pivotal role for TGF-beta in atherogenesis?Heparin rapidly and selectively regulates protein tyrosine phosphorylation in vascular smooth muscle cells.Thrombospondin 1 does not activate transforming growth factor beta1 in a chemically defined system or in smooth-muscle-cell cultures.Transcriptional and post-transcriptional control of lysyl oxidase expression in vascular smooth muscle cells: effects of TGF-beta 1 and serum deprivation.Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells.Human cytomegalovirus infection induces mRNA expression and secretion of plasminogen inhibitor type-1 in endothelial cells.Pathology of urethral fibromuscular system related to parturition-induced stress urinary incontinence and TGF-β1/Smad pathway.
P2860
Q24532213-FC90AF75-D8C4-4C6A-B485-023A7244255FQ24798392-2C4C5769-0E5D-4E2A-8E93-EC21089BBBF3Q30470066-5B128D63-809F-4E44-902E-1632AC1C24F9Q33909025-C7374F55-8DF2-44C1-8575-99B2952B0B62Q33999138-496AE462-5F7D-42ED-AC3D-4DB214FCDF53Q34575432-890810EE-EB4E-44F4-94F7-8EE1A0B1B54EQ34613526-F2A47004-51A2-4B87-8029-6469EAEDAF97Q35788816-C2307CA6-312F-4CC3-8333-C51C6E229E93Q35799761-C111C179-5F3F-4F29-B735-CA0BD09AEC54Q36190216-0B590594-0017-4CC6-B60E-F3A43233089BQ36231976-BB66B2E0-0720-44B0-A891-9C4CD29493BFQ37309267-22C6A5B5-00F7-45B2-B0A3-A829D46166D3Q38013061-478CD125-F68B-4921-807C-DF36B084F1ADQ38338004-035972AC-60EC-4C6E-A138-F192EC6863CCQ38361843-885F6B7B-636E-43A3-90E6-1B1F5E4EEAF6Q38867127-766B20EB-D1E2-44E4-95AC-E80BA5D49C8AQ38958854-7AD9D577-2296-45C6-B150-EA689095C55CQ39697059-0377AE12-CAF9-4798-B08B-A63E0DCBA833Q39795032-AC91540B-9E54-4AF5-AEF4-2C67364BC0ECQ40926437-EC42E538-6C21-469F-BAE1-E958814653F7Q40970481-1A7DFE8D-59FE-459F-9803-966DBCBE0075Q41828870-70B94F41-E9C3-412B-972B-1F0C6DD5F0A4Q42437922-1948E1C5-7275-4861-A726-D9AE4A250E5EQ42994449-363B94BF-3298-4728-A4BE-05984E063281Q47855228-B86CE93C-3C8C-4713-8512-E5350D02FEF2Q50517673-6F1BAC58-BA1C-4E33-A825-7B1585BB22E2
P2860
Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Transforming growth factor bet ...... AMP before entry into M phase.
@en
Transforming growth factor bet ...... AMP before entry into M phase.
@nl
type
label
Transforming growth factor bet ...... AMP before entry into M phase.
@en
Transforming growth factor bet ...... AMP before entry into M phase.
@nl
prefLabel
Transforming growth factor bet ...... AMP before entry into M phase.
@en
Transforming growth factor bet ...... AMP before entry into M phase.
@nl
P2093
P2860
P356
P1433
P1476
Transforming growth factor bet ...... AMP before entry into M phase.
@en
P2093
C M Witchell
D J Grainger
J C Metcalfe
P L Weissberg
P2860
P304
P356
10.1042/BJ2990227
P407
P478
299 ( Pt 1)
P577
1994-04-01T00:00:00Z